ClinicalTrials.Veeva

Menu

Mindfulness Training Plus Oxytocin Effects on Smoking Behavior (MOXY)

University of Southern California logo

University of Southern California

Status and phase

Terminated
Phase 3
Phase 2

Conditions

Smoking
Smoking Cessation

Treatments

Drug: Saline Solution
Behavioral: Sham mindfulness
Drug: Oxytocin
Behavioral: Mindfulness

Study type

Interventional

Funder types

Other

Identifiers

NCT03819231
HS-17-00972

Details and patient eligibility

About

The purpose of this study is to examine the effects of mindfulness training and a drug called oxytocin on smoking.

Full description

Mindfulness training allows individuals to be present with their own emotions, thoughts, and bodily sensations without reactive judgment, and will be given in the form of daily audio recordings. Oxytocin is a naturally occurring hormone in the brain and throughout the body. It is also an FDA-approved drug to help induce labor in pregnant women. In this study, the use oxytocin is experimental and is in the form of a nasal spray.

Enrollment

20 patients

Sex

All

Ages

18 to 40 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Smoke at least 10 cigarettes per day for the past year

Exclusion criteria

  • Current DSM-5 substance use disorder
  • Any medial condition that would increase risk for study participation
  • Women who are pregnant or nursing
  • Current use of psychiatric medication for anxiety or mood disorders
  • Planning to quit or reduce smoking in the next 30 days
  • Current regular use of other nicotine-containing products
  • Current mindfulness or mediation practice of greater than 5 minutes per day

Trial design

Primary purpose

Basic Science

Allocation

Randomized

Interventional model

Factorial Assignment

Masking

Double Blind

20 participants in 3 patient groups

Mindfulness and intranasal oxytocin
Experimental group
Description:
Given oxytocin through intranasal administration and self-directed mindfulness training.
Treatment:
Behavioral: Mindfulness
Drug: Oxytocin
Mindfulness and placebo
Active Comparator group
Description:
Given sterile saline through intranasal adminstration and self-directed mindfulness training.
Treatment:
Behavioral: Mindfulness
Drug: Saline Solution
Sham mindfulness and placebo
Sham Comparator group
Description:
Given sterile saline through intranasal adminstration and sham self-directed mindfulness training.
Treatment:
Behavioral: Sham mindfulness
Drug: Saline Solution

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems